Immediate Impact

1 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout
3 intermediate papers

Works of Satoshi Ushijima being referenced

Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan
2021
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
2020
and 2 more

Author Peers

Author Last Decade Papers Cites
Satoshi Ushijima 86 57 186 91 90 14 330
Senaka Peter 79 36 50 84 74 17 292
Nelma Clementino 36 66 102 44 121 17 335
Takeshi Kamimura 42 42 131 27 23 20 319
Ariel Masetto 51 138 116 38 21 21 332
S. Haque 182 14 79 39 34 8 355
Lucia Tornaghi 15 31 119 65 165 11 330
Ehab Saad Aldin 35 12 85 35 23 17 293
David Rosenbaum 119 34 54 46 49 14 325
Q. Meulders 31 41 54 22 28 18 328
Robert J. Verburg 22 43 122 80 31 11 308

All Works

Loading papers...

Rankless by CCL
2026